KIF2C and cancer: For example, cancer cells adapt to decreased microtubule-kinetochore dynamics and suppressed CIN induced by treatment with KIF2C/MCAK inhibitors by adjusting AURKB levels, ultimately returning the cancer cells to their original level microtubule-kinetochore dynamics and chromosome mis-segregation [195].